Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4

by Bellmunt, Joaquim
Published in Biomedicines (2018)

Salvage Systemic Therapy for Advanced Urothelial Carcinoma: On the Cusp of a Sea Change?

by Sonpavde, Guru, Bellmunt, Joaquim
Published in Oncologist (2015)

The evolving role of enzalutamide on the treatment of prostate cancer

by Nadal, Rosa, Bellmunt, Joaquim
Published in Future Oncol (2016)

Castration-resistant prostate cancer: new science and therapeutic prospects

by Bellmunt, Joaquim, Oh, William K.
Published 2010

Urothelial carcinoma management in elderly or unfit patients()

by Bellmunt, Joaquim, Mottet, Nicolas, De Santis, Maria
Published in EJC Suppl (2016)

Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer

by Merseburger, Axel S., Bellmunt, Joaquim, Jenkins, Cheryl, Parker, Chris, Fitzpatrick, John M.
Published 2013

Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer

by Merseburger, Axel S., Bellmunt, Joaquim, Jenkins, Cheryl, Parker, Chris, Fitzpatrick, John M.
Published 2013

In Reply

by Merseburger, Axel S., Bellmunt, Joaquim, Jenkins, Cheryl, Parker, Chris, Fitzpatrick, John M.
Published 2014

Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer

by Merseburger, Axel S., Bellmunt, Joaquim, Jenkins, Cheryl, Parker, Chris, Fitzpatrick, John M.
Published 2013

Upper tract urothelial carcinoma: a different disease entity in terms of management

by Leow, Jeffrey J, Chong, Kian Tai, Chang, Steven L, Bellmunt, Joaquim
Published in ESMO Open (2017)

New treatment options for metastatic renal cell carcinoma

by Rodriguez-Vida, Alejo, Hutson, Thomas E, Bellmunt, Joaquim, Strijbos, Michiel H
Published in ESMO Open (2017)

Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelia...

by Hoffman-Censits, Jean, Pal, Sumanta, Kaiser, Constanze, Ding, Beiying, Bellmunt, Joaquim
Published in J Immunother Cancer (2020)

The Evolving Understanding of MicroRNA in Bladder Cancer

by Guancial, Elizabeth A., Bellmunt, Joaquim, Yeh, Shuyuan, Rosenberg, Jonathan, Berman, David M.
Published in Urol Oncol (2013)

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

by Mickisch, Gerald HJ, Schwander, Björn, Escudier, Bernard, Bellmunt, Joaquim, Maroto, José P, Porta, Camillo, Walzer, Stefan, Siebert, Uwe
Published 2011

A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive High-Grade Metastatic Urothelial Carcinoma

by Ramírez de Olano, Amaya, Bellmunt, Joaquim, Rodrigo, Ana, Álvarez, Luis, Terrádez, Adriana, García-Foncillas, Jesús, Laes, Jean-François
Published in Case Rep Oncol (2017)

Sequential Response to FGFR3 Inhibition With Subsequent Exceptional Response to Atezolizumab in a Patient With FGFR3-TACC3 Fusion–Positive Metastatic Urothelial Carcinoma

by Nassar, Amin H., Lundgren, Kevin, Kim, Jaegil, Choueiri, Toni K., Sonpavde, Guru P., Kwiatkowski, David J., Bellmunt, Joaquim
Published in JCO Precis Oncol (2018)

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma

by Mullane, Stephanie A., Werner, Lillian, Rosenberg, Jonathan, Signoretti, Sabina, Callea, Marcella, Choueiri, Toni K., Freeman, Gordon J., Bellmunt, Joaquim
Published in Sci Rep (2016)

Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-invasive Urothelial Bladder Carcinoma

by Liu, David, Plimack, Elizabeth R., Hoffman-Censits, Jean, Garraway, Levi A., Bellmunt, Joaquim, Van Allen, Eliezer, Rosenberg, Jonathan E.
Published in JAMA Oncol (2016)

Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer

by Kamat, Ashish M., Lerner, Seth, Black, Peter, Bellmunt, Joaquim, Dinney, Colin, Hahn, Noah M., O’Donnell, Michael, Quale, Diane Z.
Published in Bladder Cancer (2017)

Improved 5-factor prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma

by Sonpavde, Guru, Pond, Gregory R., Rosenberg, Jonathan E., Bajorin, Dean F., Choueiri, Toni K., Necchi, Andrea, Di Lorenzo, Giuseppe, Bellmunt, Joaquim
Published in J Urol (2015)